Kazia Therapeutics share price today

(KZIA)

Kazia Therapeutics share price is $3.02 & ₹256.63 as on 21 Dec 2024, 2.30 'hrs' IST

$3.02

▲

-0.01

(-0.33%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Kazia Therapeutics share price in Dollar and Rupees. Guide to invest in Kazia Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Kazia Therapeutics. Get details on the Indian mutual funds that are investing in Kazia Therapeutics. Get Analyst recommendations and forecasts along with all the Kazia Therapeutics's financials.

Kazia Therapeutics share price movements

Today's Low: $2.90
Today's High: $3.16
$3.02
3.97%
Downside
Day's Volatility :8.23%
Upside
4.43%
52 Weeks Low: $1.87
52 Weeks High: $15.80
$3.02
38.21%
Downside
52 Weeks Volatility :88.19%
Upside
80.89%

Kazia Therapeutics Returns

Period	Kazia Therapeutics Ltd	Index (Russel 2000)
3 Months	-9.69%	0.0%
6 Months	33.63%	0.0%
1 Year	-29.77%	0.0%
3 Years	-96.4%	-19.7%

Kazia Therapeutics Key Statistics

in dollars & INR

Previous Close	$3.03
Open	$3.11
Today's High	$3.16
Today's Low	$2.9
Market Capitalization	$13.2M
Today's Volume	$59.7K
52 Week High	$15.8
52 Week Low	$1.866
Revenue TTM	$560.0
EBITDA	$-17.5M
Earnings Per Share (EPS)	$-6.44
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-186.37%

How to invest in Kazia Therapeutics from India?

It is very easy for Indian residents to invest directly in Kazia Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Kazia Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Kazia Therapeutics or KZIA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Kazia Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Kazia Therapeutics shares which would translate to 0.281 fractional shares of Kazia Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Kazia Therapeutics, in just a few clicks!

Returns in Kazia Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

Kazia Therapeutics investment value today

Current value as on today

₹1,31,963

Returns

₹31,963

(+31.96%)

Returns from Kazia Therapeutics Stock

₹29,767 (false-29.77%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Kazia Therapeutics

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Search volume for Kazia Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 22, 2024. 4% more investors are searching Kazia Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Kazia Therapeutics

UBS Group AG
0.57%
Morgan Stanley - Brokerage Accounts
0.51%
Citadel Advisors Llc
0.14%
Virtu Financial LLC
0.09%
JPMorgan Chase & Co
0.09%
Commonwealth Equity Services Inc
0.07%

Analyst Recommendation on Kazia Therapeutics

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Kazia Therapeutics(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Kazia Therapeutics

What analysts predicted

Upside of 534.11%

Current:

$3.02

Target:

$19.15

Insights on Kazia Therapeutics

Price Movement
In the last 7 days, KZIA stock has moved down by -14.9%
Decreasing Revenue
Revenue is down for the last 2 quarters, 555.0 → 5.0 (in $), with an average decrease of 99.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -3.43M → -8.82M (in $), with an average decrease of 64.1% per quarter
KZIA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 57.1%
KZIA vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 119.0%

Kazia Therapeutics Technicals Summary

Sell

Neutral

Buy

Kazia Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Kazia Therapeutics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Kazia Therapeutics Ltd	-47.57%	33.63%	-29.77%	-96.4%	-92.93%
Regeneron Pharmaceuticals, Inc.	-5.73%	-34.03%	-17.38%	12.23%	86.41%
Biontech Se	4.48%	30.56%	7.97%	-55.71%	237.85%
Alnylam Pharmaceuticals, Inc.	-0.55%	10.11%	28.37%	26.29%	108.55%
Vertex Pharmaceuticals Incorporated	-11.79%	-16.36%	-2.55%	77.79%	80.12%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Kazia Therapeutics Ltd	NA	NA	NA	0.0	-1.86	-0.46	NA	2.0
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Kazia Therapeutics Ltd	Buy	$13.2M	-92.93%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	86.41%	17.51	33.61%
Biontech Se	Buy	$26.7B	237.85%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	108.55%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.12%	32.84	-4.51%

About Kazia Therapeutics

innovative. focused. agile. kazia therapeutics is an agile, oncology-focused biotechnology company, based in sydney, australia. we have two clinical staged drug development candidates and an early stage discovery program, across a range of oncology indications. our lead program is gdc-0084, a small molecule inhibitor of the pi3k / akt / mtor pathway, which is being developed to treat glioblastoma multiforme, the primary and most aggressive form of brain cancer. licensed from genentech in late 2016, gdc-0084 is anticipated to enter phase ii clinical trials in 2017. trxe-002-1, or cantrixil is kazia’s second drug development candidate under development as a treatment for ovarian cancer. the chemotherapeutic is currently undergoing a phase 1 clinical trial in hospitals across australia and the united states. initial data on this trial is expected to be reported early in 2018. kazia therapeutics is trading under the following tickers: asx: kza nasdaq: kzia for more information, please visi

Organization	Kazia Therapeutics
Employees	0
CEO	Dr. John Edwin Friend II, M.D.
Industry	Health Technology

Management People of Kazia Therapeutics

Name	Title
Dr. John Edwin Friend II, M.D.	CEO, MD & Director
Ms. Gabrielle Heaton BBUS (ACC), CPA	Principal Accounting Officer, VP of Finance & Administration and Principal Financial Officer
Ms. Anna Sandham	Company Secretary

Important FAQs about investing in Kazia Therapeutics from India :

What is Kazia Therapeutics share price today?

Kazia Therapeutics share price today stands at $3.02, Open: $3.11 ; Previous Close: $3.03 ; High: $3.16 ; Low: $2.90 ; 52 Week High: $15.80 ; 52 Week Low: $1.87. The stock opens at $3.11, after a previous close of $3.03. The stock reached a daily high of $3.16 and a low of $2.90, with a 52-week high of $15.80 and a 52-week low of $1.87.

Can Indians buy Kazia Therapeutics shares?

Yes, Indians can invest in the Kazia Therapeutics (KZIA) from India.

With INDmoney, you can buy Kazia Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Kazia Therapeutics at zero transaction cost.

How can I buy Kazia Therapeutics shares from India?

It is very easy to buy Kazia Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Kazia Therapeutics be purchased?

Yes, you can buy fractional shares of Kazia Therapeutics with INDmoney app.

What are the documents required to start investing in Kazia Therapeutics stocks?

To start investing in Kazia Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.